| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | lenvatinib | CTRPv2 | pan-cancer | AAC | 0.0036 | 0.9 |
| mRNA | AZD0530 | FIMM | pan-cancer | AAC | 0.016 | 0.9 |
| mRNA | PHA-665752 | GDSC1000 | pan-cancer | AAC | -0.0046 | 0.9 |
| mRNA | HLI 373 | CTRPv2 | pan-cancer | AAC | -0.0034 | 0.9 |
| mRNA | VU0155056 | CTRPv2 | pan-cancer | AAC | 0.0035 | 0.9 |
| mRNA | CIL56 | CTRPv2 | pan-cancer | AAC | 0.0041 | 0.9 |
| mRNA | GDC-0941 | FIMM | pan-cancer | AAC | 0.016 | 0.9 |
| mRNA | JW-480 | CTRPv2 | pan-cancer | AAC | 0.0033 | 0.9 |
| mRNA | Bexarotene | GDSC1000 | pan-cancer | AAC | -0.0026 | 0.9 |
| mRNA | 17-AAG | CCLE | pan-cancer | AAC | 0.0035 | 0.9 |